Buspirone Nanovesicular Nasal System for Non-Hormonal Hot Flushes Treatment

The aim of this work was to design and characterize a new nanovesicular nasal delivery system (NDS) containing buspirone, and investigate its efficiency in an animal model for the treatment of hot flushes. The presence of multilamellar vesicles with a mean size distribution of 370 nm was evidenced b...

Descripción completa

Detalles Bibliográficos
Autores principales: Touitou, Elka, Natsheh, Hiba, Duchi, Shaher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160910/
https://www.ncbi.nlm.nih.gov/pubmed/29970859
http://dx.doi.org/10.3390/pharmaceutics10030082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160910/
https://www.ncbi.nlm.nih.gov/pubmed/29970859
http://dx.doi.org/10.3390/pharmaceutics10030082

Ejemplares similares